Currently, a group of British scientists from the universities of Manchester and Lancaster is working on the creation of a new drug, which is expected to developers, will help prevent the development of hydrocephalus in the fetus during pregnancy, as well as alleviate the condition of people suffering from this congenital disease.As informs on the pages an Internet portal medinform.biz, in the event that the work of researchers succeed, this will help to enrich the arsenal of modern medicine, which is still absent as reliable methods of prenatal diagnosis of hydrocephalus in the early stages of fetal development, and effectivetreatment for this serious illness.
British researchers led by Dr. Jalil Miyan (Jaleel Miyan) began its work with that allowed himself to doubt the validity of the conventional explanation of hydrocephalus.As you know, today is assumed that the disease develops due to the formation of excess cerebrospinal fluid accumulates in the ventricles of the brain of patients.However, British
scientists are inclined to think that the key role in the development of the pathological process should be given to changes in biochemical composition of cerebrospinal fluid, but not its excess.The authors hope that the change in the chemical composition of the liquid may accelerate its absorption and thereby normalize the sick person.
Currently, researchers are working on a completely new chemical drug, whose mission is to accelerate the processes of absorption of fluid in the ventricles of the brain.How to emphasize the developers, the new drug also can be used to prevent the development of hydrocephalus in the prenatal period.
must be said that the results of preliminary tests in development drugs (composition and method of application is not disclosed) were so effective that a number of British and American organizations of parents of children suffering from hydrocephalus, have already started to collect funds for the next stages of the research project.